Highlighter is on. Drag to highlight text. Click a highlight to remove it.
ALL / Endocrinology

Phaeochromocytoma

Phaeochromocytoma

Phaeochromocytoma is a rare catecholamine secreting tumour. About 10% are familial and may be associated with MEN type II, neurofibromatosis and von Hippel-Lindau syndrome

Basics
  • bilateral in 10%
  • malignant in 10%
  • extra-adrenal in 10% (most common site = organ of Zuckerkandl, adjacent to the bifurcation of the aorta)

Features are typically episodic
  • hypertension (around 90% of cases, may be sustained)
  • headaches
  • palpitations
  • sweating
  • anxiety

Tests
  • 24 hr urinary collection of metanephrines (sensitivity 97%)
  • this has replaced a 24 hr urinary collection of catecholamines (sensitivity 86%)

Surgery is the definitive management. The patient must first however be stabilized with medical management:
  • alpha-blocker (e.g. phenoxybenzamine), given before a
  • beta-blocker (e.g. propranolol)
+PassMedicine Notes

Phaeochromocytoma is a rare catecholamine secreting tumour. About 10% are familial and may be associated with MEN type II, neurofibromatosis and von Hippel-Lindau syndrome

Basics
  • bilateral in 10%
  • malignant in 10%
  • extra-adrenal in 10% (most common site = organ of Zuckerkandl, adjacent to the bifurcation of the aorta)
Features are typically episodic
  • hypertension (around 90% of cases, may be sustained)
  • headaches
  • palpitations
  • sweating
  • anxiety
Tests
  • 24 hr urinary collection of metanephrines (sensitivity 97%)
  • this has replaced a 24 hr urinary collection of catecholamines (sensitivity 86%)
Surgery is the definitive management. The patient must first however be stabilized with medical management:
  • alpha-blocker (e.g. phenoxybenzamine), given before a
  • beta-blocker (e.g. propranolol)


Media
Phaeochromocytoma
Townsend Teaching - YouTube
👍 18 👎 0
Phaeochromocytoma
YouTube
👍 18 👎 0
Saved ✓

MEDIA